.jpg)
The pharmaceutical industry is essential to the
global economy and is subject to a high degree of regulation. In addition to
the production of drugs, which involves a lengthy research and development
process, the selection – and protection – of brand names is crucial to
success and requires detailed knowledge of a wide range of both national and
international requirements. This guide is designed to help busy practitioners
to navigate the regulatory maze by allowing for a quick and easy international
comparison of the respective practices and procedures governing pharmaceutical
marks. To achieve this, Pharmaceutical Trademarks – A Global Guide is written
by industry experts from leading firms across the globe. Recently there is now
more work done on providing the generic name to the medicines than providing a
pharmaceutical name. For me this could be a set back as it won’t help public.
Public is now more familiar with trade names.
We all know Medicines have more than one name, a
generic name, which is the active ingredient of the medicine and the a brand
name, which is the trade name the manufacturer gives to the medicine.When a
pharmaceutical company discovers a new generic drug to treat or prevent a
condition, they put it through a series of clinical trials in order to gain
approval for marketing from the Medicines and Healthcare products Regulatory
Agency (MHRA).Once the license has been granted by the MHRA, the pharmaceutical
company can then market the generic medicine under a brand name.
This whole process needs a well known and
thorough examination. Providing public the generic name will confuse them.
There will be increase in medicinal costs. Price hike will altogether affect
the poor and the district hospitals won’t come up to take the medicines to the
poor. Public discussions should be there. Before going on for this process,
public should be interacted and discussions should take place. If generic name
will take action, public won’t be able to judge the right and the wrong drug or
whether it is substandard or whether it is spurious (i.e. fake). There are a
handful of medicines that a doctor must prescribe by the brand name because the
inactive ingredients do affect the action of the medicine. These
include:modified-release theophylline for asthma, eg Nuelin SA,
Slo-phyllin,Uniphyllin continus modified-release aminophylline for asthma, eg
Norphyllin SR,Phyllocontin continus modified-release diltiazem for angina and
high blood pressure, eg Adizem-XL, Slozem, Tildiem retard. Also there are some
anticancer drugs. If generic name is provided in them we might not have some of
the important information of the medicine and this might turn to many diseases
including glaucoma. In addition we might not be able to guess the side effects
of the medicine or if there are some sub standards in the medicine. Generic
name will provide the legislative approval and thus would have low preferences
of doctors and patients altogether.
Roughly half of all neurologists have had a
patient lose seizure control or some other new adverse reaction after switching
from brand to generic names in america. Up taking this process will affect the
people here. Summing up, my point is that the basic is always the need of hour
and switching to the platform which is unknown may turn fatal particularly in
health concerns and we all know how much health means to us.
No comments:
Post a Comment